|Primary analysis complete
|Study Start Date:
|Study Made Public:
A Phase 1 placebo-controlled clinical trial to evaluate the safety and immunogenicity of SAAVI DNA-C2 vaccine boosted by SAAVI MVA-C vaccine in HIV uninfected healthy vaccinia naive adult participants in South Africa and the United States
HVTN 073 (SAAVI 102) is a Phase I clinical trial to evaluate the safety and immunogenicity of SAAVI DNA-C2 prime / SAAVI MVA-C boost.
Sign in to see full information about this study and to download study data.
ProductsProduct info coming soon!
No integrated data is available for this study.
No non-integrated data is available for this study.